A detailed history of Israel Englander (Millennium Management LLC) transactions in Argenx Se stock. As of the latest transaction made, Millennium Management LLC holds 24,500 shares of ARGX stock, worth $10.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,500
Previous 10,000 145.0%
Holding current value
$10.5 Million
Previous $3.8 Million 153.58%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$356.95 - $413.29 $77 Million - $89.2 Million
-215,769 Reduced 62.46%
129,662 $51.1 Million
Q4 2023

Feb 14, 2024

BUY
$338.91 - $506.01 $47.3 Million - $70.6 Million
139,538 Added 67.77%
345,431 $131 Million
Q2 2023

Aug 14, 2023

BUY
$360.14 - $422.58 $8.47 Million - $9.94 Million
23,521 Added 12.9%
205,893 $80.2 Million
Q1 2023

May 15, 2023

BUY
$334.23 - $403.65 $27.7 Million - $33.5 Million
82,894 Added 83.33%
182,372 $67.9 Million
Q4 2022

Feb 14, 2023

SELL
$342.17 - $402.31 $1.27 Million - $1.49 Million
-3,700 Reduced 3.59%
99,478 $37.7 Million
Q3 2022

Nov 14, 2022

BUY
$343.2 - $395.75 $9.89 Million - $11.4 Million
28,813 Added 38.75%
103,178 $36.4 Million
Q2 2022

Aug 15, 2022

SELL
$269.58 - $378.88 $842,167 - $1.18 Million
-3,124 Reduced 4.03%
74,365 $28.2 Million
Q1 2022

May 16, 2022

BUY
$254.45 - $351.06 $197,707 - $272,773
777 Added 1.01%
77,489 $24.4 Million
Q4 2021

Feb 14, 2022

BUY
$272.01 - $353.03 $16.5 Million - $21.4 Million
60,506 Added 373.36%
76,712 $26.9 Million
Q3 2021

Nov 15, 2021

SELL
$295.0 - $350.58 $759,625 - $902,743
-2,575 Reduced 13.71%
16,206 $4.89 Million
Q2 2021

Aug 16, 2021

SELL
$257.11 - $319.92 $7,456 - $9,277
-29 Reduced 0.15%
18,781 $5.65 Million
Q1 2021

May 17, 2021

BUY
$268.3 - $380.31 $3.99 Million - $5.66 Million
14,881 Added 378.75%
18,810 $5.18 Million
Q4 2020

Feb 16, 2021

SELL
$248.13 - $308.36 $12.1 Million - $15.1 Million
-48,888 Reduced 92.56%
3,929 $1.16 Million
Q2 2020

Aug 14, 2020

BUY
$127.44 - $232.72 $2.04 Million - $3.72 Million
15,984 Added 43.4%
52,817 $11.9 Million
Q1 2020

May 14, 2020

BUY
$108.83 - $165.23 $282,631 - $429,102
2,597 Added 7.59%
36,833 $4.85 Million
Q4 2019

Feb 14, 2020

SELL
$106.59 - $164.21 $8.66 Million - $13.3 Million
-81,227 Reduced 70.35%
34,236 $5.5 Million
Q3 2019

Nov 14, 2019

BUY
$113.31 - $150.51 $11.2 Million - $14.9 Million
98,811 Added 593.39%
115,463 $13.2 Million
Q2 2019

Aug 15, 2019

SELL
$115.0 - $141.58 $4.24 Million - $5.21 Million
-36,828 Reduced 68.86%
16,652 $2.36 Million
Q2 2019

Aug 14, 2019

BUY
$115.0 - $141.58 $3.42 Million - $4.21 Million
29,746 Added 125.33%
53,480 $3.2 Million
Q1 2019

May 14, 2019

SELL
$98.85 - $134.59 $1.93 Million - $2.62 Million
-19,479 Reduced 45.08%
23,734 $2.96 Million
Q4 2018

Feb 14, 2019

SELL
$63.81 - $109.82 $3.97 Million - $6.83 Million
-62,231 Reduced 59.02%
43,213 $4.15 Million
Q3 2018

Nov 14, 2018

SELL
$75.5 - $96.63 $14.6 Million - $18.7 Million
-193,177 Reduced 64.69%
105,444 $8 Million
Q2 2018

Aug 14, 2018

SELL
$74.84 - $100.16 $39.9 Million - $53.4 Million
-533,555 Reduced 64.12%
298,621 $24.7 Million
Q1 2018

May 15, 2018

BUY
$56.95 - $85.19 $13.5 Million - $20.2 Million
236,662 Added 39.74%
832,176 $66.9 Million
Q4 2017

Feb 14, 2018

BUY
$22.57 - $63.56 $13.4 Million - $37.9 Million
595,514
595,514 $37.6 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $23.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.